Fact CheckerSign in

NCT06849050Completed

The Influence of Acute Continuous Exercise and Adiposity on Appetite Hormones and Neural Correlates of Visual Food Cues

Source: ClinicalTrials.gov · Last updated 10 Sept 2025

Brief summary (registry, in English)

Exercise increases energy expenditure and impacts appetite and energy intake. Some appetite-related hormones such as oxyntomodulin suppress appetite whilst other hormones such as ghrelin stimulate appetite. This study will investigate whether acute continuous walking/jogging influences these hormone concentrations, and whether exercise-induced changes in the hormones correlate with perceptions of appetite, nutritional intake and brain activity in individuals varying in weight status.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
18 Feb 2025
Start date
5 Jul 2024
Primary completion date
3 Sept 2025
Lead sponsor
Loughborough University
Diseases
Obesity
NCT number
NCT06849050

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 5 Jul 2024 to the primary completion date, 3 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Taking any medication which may affect the study outcomes (e.g. liraglutide, semaglutide, insulin, steroids, anti-psychotics)
  • Previous bariatric surgery (e.g. gastric bypass, gastric band, sleeve gastrectomy)

Other illness

  • Known medical conditions (e.g. diabetes, heart condition)
  • Clinically diagnosed eating disorder
  • Food allergies or intolerances, or severe dislikes to study foods

Other

  • Smokers (vaping is considered smoking in this study)
  • Pregnant or breastfeeding
  • Have recently donated blood (within eight weeks of visits 2 and 3).

Who the study is looking for

  • Body mass index (BMI) between 18.5 - 24.9 kg/m2 and a waist circumference of ≤ 88 cm for women, and ≤ 102 cm for men or a BMI between 25 - 40 kg/m2 and a waist circumference of \> 88 cm for women, and \> 102 cm for men. BMI and waist circumference thresholds vary amongst ethnicities. People with a South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family background are prone to central adiposity and their cardiometabolic risk occurs at a lower BMI. Therefore, the following BMI and waist circumference thresholds will be applied for people of South Asian, other Asian, Black African and African-Caribbean ethnicity: (1) BMI 18.5 kg/m2 to 23 kg/m2 and waist circumference of \< 90 cm for men and \< 80 cm for women; (2) BMI 23.1 kg/m2 to 40 kg/m2 and waist circumference of ≥ 90 cm for men and ≥ 80 cm for women.
  • Normally consumes three meals a day
  • Able to walk continuously for 1 hour on a treadmill
  • Weight stable for 3 months (\< 3kg change in weight)
  • Regular menstrual cycle for the last 6 months (people taking the combined contraceptive pill are eligible for the study)
  • Able to undergo a 45-minute MRI scan

Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Loughborough University
Coordinator of this site? Confirm its status
LoughboroughUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.